Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
To evaluate the efficacy and safety of solifenacin succinate as add-on therapy for overactive bladder (OAB) symptoms in men who have been treated for benign prostatic hyperplasia (BPH) with tamsulosin hydrochloride for at least 6 weeks
Epistemonikos ID: 0ecc6d17cfe700a8c1467cbc866109650fe675bb
First added on: May 05, 2024